Cirurgia Gastrintestinal
Estudo randomizado | Dieta pobre em resíduos 1 dia antes da colonoscopia demonstra melhora na qualidade da preparação intestinal e na tolerância do paciente em relação à dieta com líquidos claros.
14 Jun, 2021 | 11:00hDiretriz: Diagnóstico e tratamento do sangramento intestinal baixo agudo.
3 Jun, 2021 | 09:56hDiretrizes de Práticas Clínicas da AGA sobre o tratamento médico da Doença de Crohn fistulizante luminal e perianal moderada a grave
1 Jun, 2021 | 10:11hComunicado de imprensa: AGA recommends early use of biologics in patients with moderate-to-severe Crohn’s disease – American Gastroenterology Association
Revisão técnica: AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease
Ferramenta de apoio à decisão médica / Algoritmo: Medical Management of Adult Outpatients With Moderate to Severe Lunminal Crohn’s Disease
Comentário no Twitter
Here are the @AmerGastroAssn guidelines on the management of moderate-severe Crohn disease. #GITwitter #GI #gut #IBD https://t.co/VlT4xTUE8t pic.twitter.com/ayYlpVkkod
— John Damianos, M.D. (@john_damianosMD) May 28, 2021
Podcast | Cirurgia bariátrica para o clínico – Seleção do paciente, conduta perioperatória e cuidado pós-operatório.
25 Mai, 2021 | 15:44h#275 Bariatric Surgery for the Internist with Dr. Vivian Sanchez – The Curbsiders
Estudo randomizado: Quimioterapia de intensidade reduzida em pacientes idosos frágeis com câncer gastresofágico avançado propicia uma melhor experiência ao paciente, sem perda significativa no controle da doença.
20 Mai, 2021 | 10:42h
Comentário no Twitter
The GO2 trial tested reduced intensity of chemo for pts w adv gastroesophageal cancer & found reducing intensity led to comparable survival but w improved patient experience, & decision-making can be enhanced using geriatric assessment https://t.co/DtZOXcozo7 #GeriOnc
— JAMA Oncology (@JAMAOnc) May 13, 2021
Resultados de longo prazo em estudo randomizado confirmam os benefícios da quimiorradioterapia neoadjuvante somada à cirurgia para câncer esofágico.
20 Mai, 2021 | 10:41h
Comentários no Twitter
Out at @ASCO_pubs
🔟yr Outcome of Neoadj #Chemoradiotherapy➕Surgery for #EsophagealCancer☑️Show OS benefit in locally advanced resectable esophageal or junctional #Cancer who receive preop chemorad🧪☢️ According to CROSS, persists at least🔟years‼️https://t.co/yJSibSveAh pic.twitter.com/UssnzuFiEe
— Gil Morgan (@weoncologists) May 14, 2021
Survival benefit of preoperative chemoradiotherapy for patients with esophageal cancer persists – 10-year outcome of the CROSS trial https://t.co/s02sMVpYhI #esocsm #JCO @ErasmusMC @bmeyck pic.twitter.com/2JwV0iOvoB
— ASCO Publications (@ASCO_pubs) May 5, 2021
Diretriz USPSTF: Iniciar o rastreamento para câncer colorretal aos 45 anos para a maioria dos pacientes.
19 Mai, 2021 | 09:39hScreening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Relatório de evidências: Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Editoriais: US Preventive Services Task Force Recommendations for Colorectal Cancer Screening: Forty-Five Is the New Fifty – JAMA E Updated USPSTF Guidelines for Colorectal Cancer Screening: The Earlier the Better – JAMA Surgery E Colorectal Cancer Screening Starting at Age 45 Years—Ensuring Benefits Are Realized by All – JAMA Network Open
Entrevista com o autor: USPSTF Recommendation: Screening for Colorectal Cancer
Página do paciente JAMA: Screening for Colorectal Cancer
Diretrizes Clínicas ACG: Prevenção, diagnóstico e tratamento das infecções por Clostridioides difficile.
19 Mai, 2021 | 09:36h
Comentário no Twitter
📢New ACG Clinical Guideline on Prevention, Diagnosis & Treatment of C. difficile Infections
Focus on clinical challenges – diagnostic issues in diarrhea, distinguishing C. diff colonization from active infection + eval/mgmt of CDI in IBD
Full guideline: https://t.co/QTCzeLB9Ri pic.twitter.com/mqZUN4r4jA
— AJG – The American Journal of Gastroenterology (@AmJGastro) May 18, 2021
Guia para potencializar a recuperação de pacientes oncológicos submetidos a cirurgia: ERAS para pacientes de cirurgia citorredutora com ou sem quimioterapia hipertérmica intraperitoneal.
19 Mai, 2021 | 09:24hDiretrizes relacionadas:
Ver também: Enhanced Recovery After Surgery (ERAS) Society Guidelines
Estudo randomizado: Entre pacientes com câncer esofágico, anastomose intratorácica após esofagectomia total ou híbrida minimamente invasiva resultou em menores taxas de vazamento anastomótico e melhores desfechos quando comparada com anastomose cervical.
18 Mai, 2021 | 10:38hIntrathoracic vs Cervical Anastomosis After Totally or Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer: A Randomized Clinical Trial – JAMA Surgery (gratuito por tempo limitado)
Comentário convidado: Does the Location Matter for the Anastomosis for Minimally Invasive Esophagectomy? (gratuito por tempo limitado)
Comentário no Twitter
Intrathoracic anastomosis after MIE is associated with a lower anastomotic leakage rate and better outcome for patients with mid to distal esophageal or gastro-esophageal junction cancer: results of the ICAN trial https://t.co/CXv2CeCnuX pic.twitter.com/QCYg4UJeyF
— JAMA Surgery (@JAMASurgery) May 12, 2021